共查询到20条相似文献,搜索用时 31 毫秒
1.
C Michael Gibson Sabina A Murphy Ajay J Kirtane Robert P Giugliano Christopher P Cannon Elliott M Antman Eugene Braunwald 《Journal of the American College of Cardiology》2004,44(5):980-987
OBJECTIVES: We sought to determine if an underlying mechanism of the association between prolonged symptom-to-treatment times and adverse outcomes may be an association of symptom-to-treatment times with impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades (TMPGs). BACKGROUND: Prolonged symptom duration among ST-segment elevation myocardial infarction (STEMI) patients undergoing fibrinolytic therapy is associated with adverse outcomes. METHODS: Angiography was performed 60 min after fibrinolytic administration in 3,845 Thrombolysis In Myocardial Infarction (TIMI) trial patients. RESULTS: The median time from symptom onset to treatment was longer among patients with impaired myocardial perfusion (3.0 h for TMPG 0/1 vs. 2.7 h for TMPG 2/3; p = 0.001). In a multivariate model, impaired tissue perfusion (TMPG 0/1) remained associated with increased time to treatment (odds ratio 1.14 per hour of delay; p = 0.007) even after adjusting for Thrombolysis In Myocardial Infarction flow grade (TFG) 3, left anterior descending infarct location, and baseline clinical characteristics. Impaired myocardial perfusion after rescue/adjunctive percutaneous coronary intervention (PCI) was associated with longer median times to treatment (3.0 h for TMPG 2/3 vs. 2.7 h for TMPG 0/1; p = 0.017), as was abnormal epicardial flow after rescue/adjunctive PCI (3.3 h for TFG 0/1/2 vs. 2.8 h for TFG 3; p = 0.005). Thirty-day mortality was associated with longer time from onset of symptoms to treatment (6.6% mortality for time to treatment >4 h vs. 3.3%; p < 0.001), even among patients undergoing rescue PCI. CONCLUSIONS: A prolonged symptom to treatment time among STEMI patients is associated with impaired myocardial perfusion independent of epicardial flow both immediately after fibrinolytic administration and after rescue/adjunctive PCI. These data provide a pathophysiologic link between prolonged symptoms due to vessel occlusion, impaired myocardial perfusion, and poor clinical outcomes. 相似文献
2.
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy 总被引:10,自引:0,他引:10
Gibson CM Pride YB Buros JL Kunadian V Southard MC Harrigan CJ Ciaglo LN Sabatine MS Cannon CP Braunwald E 《The American journal of cardiology》2008,101(9):1232-1238
In patients with ST-segment elevation myocardial infarction (STEMI), the restoration of normal epicardial flow following fibrinolytic administration is associated with improved clinical outcomes. The goal of this analysis was to examine the relation between hyperemic flow and outcomes following fibrinolytic administration for STEMI. In Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis In Myocardial Infarction 28 (CLARITY-TIMI 28), patients with STEMI (n=3,491) treated with fibrinolytic therapy were scheduled to undergo angiography 48 to 192 hours after randomization. Corrected TIMI frame count (CTFC) and TIMI myocardial perfusion grade (TMPG) were assessed, and their associations with outcomes at 30 days were evaluated. When evaluating initial angiography of the infarct-related artery, there was a nearly linear relation between CTFC and 30-day mortality, with faster flow (lower CTFC) associated with improved outcomes. Conversely, in patients who underwent percutaneous coronary intervention (PCI), very fast flow (CTFC<14) after intervention was associated with worse outcomes. Post-PCI hyperemic flow (CTFC<14) was associated with a higher incidence of mortality (p=0.056), recurrent myocardial infarction (p=0.011), and a composite of death or myocardial infarction (p<0.001) compared with normal flow (CTFC 14 to 28). When post-PCI CTFC was further stratified by TMPG, there was a U-shaped relation between mortality and CTFC in patients with poor myocardial perfusion (TMPG 0 or 1). This relation appeared to be linear in patients with TMPG 2 or 3. In conclusion, in patients who undergo PCI after fibrinolytic therapy for STEMI, hyperemic flow on coronary angiography is associated with an increased incidence of adverse outcomes. Hyperemic flow with associated impaired myocardial perfusion may be a marker of more extensive downstream microembolization. 相似文献
3.
Araszkiewicz A Grajek S Lesiak M Prech M Pyda M Janus M Cieslinski A 《The American journal of cardiology》2006,98(6):725-728
We assessed the effect of impaired myocardial blush after primary coronary intervention (PCI) on left ventricular remodeling in patients with ST-segment elevation myocardial infarction (STEMI). The study population consisted of 145 patients with first anterior STEMI that was treated successfully (Thrombolysis In Myocardial Infarction grade 3 flow) with PCI. Left ventricular remodeling was defined as an increase of > or =20% in end-diastolic volume based on repeated echocardiographic measurements in patients. The study population was divided into 2 groups according to the presence (myocardial blush grade [MBG] 2 to 3, n = 86) or absence (MBG 0 to 1, n = 59) of myocardial reperfusion. Left ventricular remodeling appeared in 21% of the entire study group. Poor myocardial blush after PCI was associated with an increased rate of remodeling compared with good myocardial reperfusion (32% vs 14%, hazard ratio 2.308, 95% confidence interval [CI] 1.21 to 4.39, p=0.014). Symptoms of heart failure were observed significantly more often in patients with MBG 0 to 1 (35.6% vs 18.6%, p = 0.032) than in patients with MBG 2 to 3. In multivariate analysis, only age (odds ratio 0.96, 95% CI 0.92 to 0.99, p = 0.02) and MBG 0 to 1 (odds ratio 3.15, 95% CI 1.35 to 7.31, p = 0.008) were associated with left ventricular dilation. In conclusion, impaired microvascular reperfusion is associated with left ventricular remodeling and development of congestive heart failure in patients with anterior STEMI that is treated with primary coronary angioplasty. 相似文献
4.
Pérez de Prado A Fernández-Vázquez F Cuellas JC Alonso-Orcajo N Carbonell R Pascual C Olalla C Diego A de Miguel A Calabozo RG 《The American journal of cardiology》2006,97(6):798-803
The interindividual response to antiplatelet treatment is considerable, with the magnitude of response often related to the appearance of clinical events after elective percutaneous coronary intervention (PCI). We investigated whether platelet aggregation inhibition (PAI) by early administration of abciximab would affect myocardial reperfusion outcomes observed after PCI in patients with acute ST-elevation myocardial infarction (STEMI). Consecutive patients with STEMI who were treated with PCI in our center were recruited (n = 56). Successful reperfusion was defined as a final Thrombolysis In Myocardial Infarction grade 3 flow, myocardial blush grade 2 or 3, and ST-segment resolution >50%. PAI grade was determined with the Ultegra Rapid Platelet Function Assay. Successful reperfusion criteria were observed in 34 patients (61%). There were 6 patients (11%) with a PAI value <80% and 34 (61%) with a PAI value > or =95%. Eight patients (36%) of those whose PAI was <95% had all the indicators of successful reperfusion compared with 26 patients (77%) whose PAI was > or =95% (p = 0.005). After adjusting for other variables (time from symptom onset to balloon, which was independently associated with myocardial reperfusion), the relation remained significant (p = 0.006). In conclusion, in patients with STEMI that was treated with direct PCI, higher platelet inhibition responses with early administration of abciximab were associated with better myocardial reperfusion outcomes. 相似文献
5.
Cox DA Stone GW Grines CL Stuckey T Zimetbaum PJ Tcheng JE Turco M Garcia E Guagliumi G Iwaoka RS Mehran R O'Neill WW Lansky AJ Griffin JJ;CADILLAC Investigators 《The American journal of cardiology》2006,98(3):331-337
We determined the outcomes of patients with acute ST-segment elevation (STE) myocardial infarction (STEMI) and non-STEMI (NSTEMI) after primary percutaneous coronary intervention (PCI). The prognosis after primary PCI in STEMI has been extensively studied and defined. Outcomes of patients who undergo primary PCI for NSTEMI are less well established. In total, 2,082 patients with ongoing chest pain for > 30 minutes consistent with acute MI were randomized to balloon angioplasty versus stenting, each with/without abciximab. Of 1,964 patients, STEMI was present in 1,725 (87.8%) and NSTEMI in 239 (12.2%). Compared with STEMI, those with NSTEMI were more likely to have delayed time-to-hospital arrival (2.4 vs 1.8 hours, p = 0.0002) and increased door-to-balloon time (3.2 vs 1.9 hours, p < 0.0001). Patients with NSTEMI were more likely to have Thrombolysis In Myocardial Infarction grade 3 flow at baseline (37.3% vs 19.4%, p < 0.0001) and higher ejection fraction (58.7% vs 55.8%, p = 0.001), but similar rates of postprocedural Thrombolysis In Myocardial Infarction grade 3 flow. At 1 year, patients with NTEMI had similar mortality (3.4% vs 4.4%, p = 0.40) but higher rates of major adverse cardiac events (24.0% vs 16.6%, p = 0.007) that was driven by more frequent ischemic target vessel revascularization (21.8% vs 11.9%, p <0.0001). In conclusion, patients with acute MI without STE who are treated with primary PCI have marked delays to treatment, similar late mortality, and increased rates of ischemic target vessel revascularization compared with patients with STEMI, despite more favorable angiographic features at presentation and similar reperfusion success. The adverse prognosis of patients with NSTEMI should be recognized and efforts made to decrease reperfusion times. 相似文献
6.
Gibson CM Kirtane AJ Boundy K Ly H Karmpaliotis D Murphy SA Giugliano RP Cannon CP Antman EM Braunwald E;TIMI Study Group 《Journal of the American College of Cardiology》2005,45(3):357-362
OBJECTIVES: We hypothesized that <0% residual stenosis (RS) after rescue/adjunctive percutaneous coronary intervention (PCI) following fibrinolytic administration in ST-segment elevation myocardial infarction (STEMI) would be associated with improved outcomes. BACKGROUND: Prior studies have associated larger lumen diameters after PCI with reduced rates of restenosis and target vessel revascularization. METHODS: Data were drawn from 748 patients with open epicardial arteries and with optimal luminal results (RS <20%) following rescue/adjunctive PCI after fibrinolytic administration in six STEMI trials. Patients were divided into two groups: 1) <0% RS and 2) 0% to 20% RS. RESULTS: A RS <0% was associated with greater gains in lumen diameter and smaller reference diameters after PCI (p < 0.001 for each), with a trend toward less frequent Thrombolysis In Myocardial Infarction flow grade (TFG) 3. A RS <0% was associated with a greater incidence of abnormal post-PCI Thrombolysis In Myocardial Infarction myocardial perfusion grades (TMPGs) (odds ratio 2.6 [1.2 to 5.9] for TMPG 0/1/2, p = 0.02), even when the analysis was restricted to patients with post-PCI TFG 3. CONCLUSIONS: A RS <0% following rescue/adjunctive PCI after fibrinolytic therapy for STEMI was independently associated with a reduction in the frequency of normal myocardial perfusion. Potential mechanisms of this finding include greater downstream embolization, increased stimulation of arterial stretch receptors with resultant coronary vasoconstriction, and increased vessel-wall injury after PCI. These findings suggest that additional prospective studies are needed to assess optimal RS that minimizes long-term restenosis without adverse effects. 相似文献
7.
直接经皮冠状动脉介入治疗患者血浆高敏C反应蛋白水平与心肌灌注的相关性研究 总被引:6,自引:0,他引:6
目的分析急性心肌梗死患者入院时血浆高敏C反应蛋白(hs-CRP)水平和直接经皮冠状动脉介入治疗(PCI)术后心肌灌注的关系。方法选择2001年10月—2004年12月在我院住院治疗的首发急性心肌梗死患者197例,其中男154例,女43例,平均年龄(60.94±11.62)岁。TIMI心肌灌注分级(TIMImyocardialperfusiongrade,TMPG)0~1级患者为Ⅰ组(n=39,19.8%),TMPG2~3级患者为Ⅱ组(n=158,80.2%)。所有入选患者第一次空腹静脉血检测甘油三酯、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、hs-CRP;并在发病后2、6、10、12、16、24、48、72h静脉抽血测定肌酸激酶同工酶;发病48h内超声心动图测定左室射血分数值。结果两组患者之间年龄、性别、病史差异无统计学意义。Ⅰ组与Ⅱ组比较,入院时血浆hs-CRP水平差异有统计学意义[(8.29±4.75)mg/L比(6.38±4.73)mg/L,P=0.026]。肌酸激酶峰值[(3017.85±1901.19)U/L比(2701.41±1992.97)U/L]、肌酸激酶同工酶峰值[(442.37±333.29)U/L比(355.91±287.99)U/L]、发病到球囊扩张的时间两组间差异无统计学意义。结论hs-CRP是炎性反应的标志物,反映了斑块局部的稳定性;直接PCI患者血浆hs-CRP水平是PCI术后心肌再灌注不良的重要影响因素。 相似文献
8.
Zhang DP Ge YG Wang LF Wang HS Li WM Xu L Ni ZH Xia K Lian Y Xue YL Yang XC 《中华心血管病杂志》2010,38(6):488-492
目的 探讨急性心肌梗死急诊经皮冠状动脉介入治疗(PCI)后心肌再灌注状态不良的发生率及其对近、远期临床预后的影响.方法 回顾性收集964例急性ST段抬高心肌梗死(STEMI)行急诊PCI治疗患者的临床资料、冠状动脉造影资料与心电图,以ST段回落程度与心肌梗死溶栓试验心肌灌注(TMP)分级等指标评估心肌再灌注状态.患者分为4组:A组为ST段回落率≥50%并且术后TMP分级为Ⅲ级;B组为ST段回落率<50%并且术后TMP分级为Ⅲ级;C组为ST段回落率≥50%并且术后TMP分级≤Ⅱ级;D组为ST段回落率<50%并且术后TMP分级≤Ⅱ级.以A组代表心肌灌注状态良好者,D组代表心肌灌注状态不良者.分析心肌再灌注不良患者的发生率及其对近远期预后的影响.结果 STEMI急诊PCI术后梗死相关动脉前向血流达到TIMIⅢ级而TMP分级为Ⅱ级以下者占27.3%(237/964),心电图ST段回落小于50%者占30.6%(266/964).11.31%(109/964)的患者发生远端栓塞.A组占总例数的48.9%(425/964),D组占总例数的10.5%(91/964).与A组比较,D组患者在住院期间(RR=64.63,P<0.01)以及随访期间(RR=11.69,P<0.01)均有较高的主要不良心脏事件发生风险.结论 急性心肌梗死急诊PCI后不到50%的患者心肌再灌注良好,心肌再灌注状态与近、远期临床预后显著相关. 相似文献
9.
冠状动脉内应用维拉帕米对急性心肌梗死急诊介入治疗后冠状动脉灌注、心肌灌注和临床预后的影响 总被引:2,自引:0,他引:2
目的探讨急性ST段抬高性心肌梗死(STEMI)急诊经皮冠状动脉介入治疗(PCI)时冠状动脉内应用维拉帕米对冠状动脉灌注、心肌灌注及临床预后的影响。方法本研究为前瞻性、随机、双盲、对照性临床研究。连续性入选99例STEMI拟行急诊PCI的患者,随机分为维拉帕米组与对照组。在支架释放后即刻,维拉帕米组在靶血管内注入维拉帕米200μg,对照组在靶血管内注入肝素生理盐水,比较两组PCI术前、术后和冠状动脉内注药后的冠状动脉灌注和心肌灌注的差别。冠状动脉灌注以心外膜TIMI血流(TFG)和校正的TIMI血流帧数计数(CTFC)来评价。心肌灌注以TIMI心肌灌注分级(TMPG)和心肌灌注显影(MBG)来评价。并比较两组在PCI术后1周心脏彩色超声结果、住院期间以及随访期间主要心脏不良事件(MACE)发生率上的差别。结果最终91例患者有完整资料,其中维拉帕米组47例,对照组44例,两组临床基本特征和造影特征相仿。维拉帕米组和对照组在术前和支架释放后即刻冠状动脉灌注和心肌灌注各指标差异均无统计学意义(P〉0.05)。冠状动脉内注入维拉帕米后,维拉帕米组的CTFC、TFG、MBG、TMPG均较对照组有显著改善,分别为CTFC:27.1±14.2比39.0±23.8,P=0.011;TFG≥2级:100%比90.9%,P=0.035;MBG≥2级:91.5%%比75.5%,P=0.034;TMPG≥2级:89.4%比72.7%,P=0.042。维拉帕米组和对照组PCI术后1周时左室射血分数(63.4%±8.2%比63.5%±10.3%,P=0.578)、院内MACE发生率(4.3%比9.1%,P=0.613)和3个月MACE发生率(23.9%比22.7%,P=0.894)差异均无统计学意义。结论STEMI患者急诊行PCI治疗时,冠状动脉内应用维拉帕米可显著改善冠状动脉灌注和心肌灌注水平,但未观察到其对急诊PCI术后心室重构和短期临床预后的显著影响。 相似文献
10.
Appelbaum E Kirtane AJ Clark A Pride YB Gelfand EV Harrigan CJ Kissinger KV Manning WJ Gibson CM 《Journal of thrombosis and thrombolysis》2009,27(2):123-129
Background Impairment of coronary microvascular perfusion is common among patients with ST-segment elevation myocardial infarction (STEMI)
treated with primary percutaneous coronary intervention (PCI). Cardiovascular magnetic resonance imaging (CMR) can identify
microvascular obstruction (MO) following reperfusion of STEMI. We hypothesized that myocardial perfusion, as assessed by the
Thrombolysis in Myocardial Infarction (TIMI) Myocardial Perfusion Grade (TMPG), would be associated with a CMR metric of MO
in this population. Methods Twenty-one STEMI patients who underwent successful primary PCI were evaluated. Contrast-enhanced CMR was performed within
7 days of presentation and repeated at three months. TIMI Flow Grade (TFG), corrected TIMI Frame Count (cTFC), TMPG, MO, infarct
size, and left ventricular ejection fraction (EF) were assessed. Results The median peak creatine phosphokinase (CPK) was 1,775 IU/l (interquartile range 838–3,321). TFG 3 was present following PCI
in 19 (90%) patients. CMR evidence of MO was present in 52% following PCI. Abnormal post-PCI TMPG (0/1/2) was present in 48%
of subjects and was associated with MO on CMR (90% MO with TMPG 0/1/2 vs. 18% MO with TMPG 3, P < 0.01). Abnormal post-PCI TMPG was also associated with a greater peak CK (median 3,623 IU/l vs. 838 IU/l, P < 0.001) and greater relative infarct size (17.3% vs. 5.2%, P < 0.01). Conclusion Among STEMI patients undergoing primary PCI, post-PCI TMPG correlates with CMR measures of MO and infarct size. The combined
use of both metrics in a comprehensive assessment of microvascular integrity and infarct size following STEMI may aid in the
evaluation of future therapeutic strategies. 相似文献
11.
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction 总被引:6,自引:0,他引:6
Timmer JR Ottervanger JP de Boer MJ Dambrink JH Hoorntje JC Gosselink AT Suryapranata H Zijlstra F van 't Hof AW;Zwolle Myocardial Infarction Study Group 《Journal of the American College of Cardiology》2005,45(7):999-1002
OBJECTIVES: This study was designed to investigate whether elevated glucose is associated with impaired Thrombolysis In Myocardial Infarction (TIMI) flow before primary percutaneous coronary intervention (PCI). BACKGROUND: Reperfusion before primary PCI in patients with ST-segment elevation myocardial infarction (STEMI) is associated with an improved outcome. Hyperglycemia in patients with STEMI is associated with an adverse prognosis. Hyperglycemia may induce a pro-thrombotic state and therefore be of influence on TIMI flow before PCI. METHODS: A total of 460 consecutive patients with STEMI treated with primary PCI were included in this analysis. Hyperglycemia was defined as a glucose > or =7.8 mmol/l (140 mg/dl). RESULTS: Hyperglycemia was observed in 70% and TIMI flow grade 3 before primary PCI in 17% of the patients. Patients with hyperglycemia less often had TIMI flow grade 3 before primary PCI (12% vs. 28%, p < 0.001). After adjustment for differences in baseline variables, hyperglycemia was a strong predictor of absence of reperfusion before primary PCI (odds ratio 2.6, 95% confidence interval 1.5 to 4.5). CONCLUSIONS: Hyperglycemia in patients with STEMI is an important predictor of impaired epicardial flow before reperfusion therapy has been initiated. Investigation of methods improving coronary flow before primary PCI in these patients is warranted. 相似文献
12.
Joost D.E. Haeck MD Youlan L. Gu MD Mathijs Vogelzang MD PhD Luc Bilodeau MD Mitchell W. Krucoff MD Jan G.P. Tijssen PhD Robbert J. De Winter MD PhD Felix Zijlstra MD PhD Karel T. Koch MD PhD 《Catheterization and cardiovascular interventions》2010,75(5):701-706
Objectives : The aim of the study was to evaluate whether the “Quantitative Blush Evaluator” (QuBE) score is associated with measures of myocardial reperfusion in patients with ST‐segment elevation myocardial infarction (STEMI) treated in two hospitals with 24/7 coronary intervention facilities. Background : QuBE is an open source computer program to quantify myocardial perfusion. Although QuBE has shown to be practical and feasible in the patients enrolled in the Thrombus Aspiration during Percutaneous Coronary Intervention in Acute Myocardial Infarction Study (TAPAS), QuBE has not yet been verified on reperfusion outcomes of primary percutaneous coronary intervention (PCI) patients treated in other catheterization laboratories. Methods : Core lab adjudicated angiographic outcomes and QuBE values were assessed on angiograms of patients who were enrolled in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST‐Elevation (PREPARE) trial. ST‐segment resolution immediately after PCI measured by continuous ST Holter monitoring was calculated by a blinded core lab. Results : The QuBE score could be assessed on 229 of the 284 angiograms (81%) and was significantly associated with visually assessed myocardial blush grade (P < 0.0001). Patients with improved postprocedural Thrombolysis in Myocardial Infarction‐graded flow, myocardial blush grade, ST‐segment resolution immediately after PCI, or a small infarct size measured by peak CK‐MB had a significant better QuBE score. Conclusions : QuBE is feasible and applicable at angiograms of patients with STEMI recorded at other catheterization laboratories and is associated with measures of myocardial reperfusion. © 2010 Wiley‐Liss, Inc. 相似文献
13.
Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarction 总被引:3,自引:0,他引:3
Guetta V Mosseri M Shechter M Matetzky S Assali A Almagor Y Gruberg L Benderly M Lotam C Kornowski R;UpFlow MI Study Investigators 《The American journal of cardiology》2007,99(7):911-915
Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) achieves a high epicardial reperfusion rate; however, it is often suboptimal in achieving myocardial reperfusion due to distal embolization of atherothrombotic particles. The present study assessed whether the capture of embolic particles during PCI would improve myocardial reperfusion outcome. In a multicenter, prospective, randomized, controlled study, 100 patients with STEMI and coronary angiographic evidence of thrombotic occlusion were randomly assigned to PCI using the FilterWire EZ (n=51) or a control group (n=49) using regular guidewires. The FilterWire EZ was successfully delivered across the lesion in 84% of patients in the FilterWire EZ group. Primary efficacy end points, including markers of epicardial (Thrombolysis In Myocardial Infarction grade flow) and myocardial reperfusion (myocardial blush score and percent early resolution of ST-segment elevation), did not differ between the 2 study groups. Further, 60- and 90-minute percent ST-segment resolutions were identical in the 2 groups. In a subgroup analysis, a blush score of 3 was achieved in 94% of patients in whom the filter's landing zone was in a vessel diameter>2.5 mm compared with only 55% in those with smaller vessel diameter (p=0.04). This corresponds to a better debris capture in filters located in large versus small vessels (p=0.08). In conclusion, in patients with STEMI, use of the FilterWire EZ as an adjunct to primary PCI did not improve angiographic or electrocardiographic measurements of reperfusion compared with conventional PCI only. 相似文献
14.
Timmer JR van der Horst IC de Luca G Ottervanger JP Hoorntje JC de Boer MJ Suryapranata H Dambrink JH Gosselink M Zijlstra F van 't Hof AW;Zwolle Myocardial Infarction Study Group 《The American journal of cardiology》2005,95(11):1375-1377
Patients with diabetes mellitus (DM) have an adverse prognosis after ST-segment elevation myocardial infarction (STEMI). Whether DM was associated with impaired myocardial reperfusion after successful primary percutaneous coronary intervention for STEMI was investigated. Myocardial reperfusion was assessed by ST-segment resolution and myocardial blush grade (MBG). A total of 386 patients were studied, of whom 64 (17%) had DM. These patients more frequently had reduced MBG (20% vs 10%, p = 0.02) and incomplete ST-segment resolution (55% vs 35%, p = 0.02) compared with patients without DM. After multivariate analysis, DM was still associated with impaired ST resolution (odds ratio 2.1, p = 0.03) and reduced MBG (odds ratio 2.2, p = 0.03). 相似文献
15.
目的观察中性粒细胞/淋巴细胞比值(neutrophil/lymphocyte ratio,NLR)对判断急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗后患者的心肌灌注和预后的影响。方法选取接受直接PCI治疗的急性STEMI患者551例,根据入院第一次NLR,将患者按照四分位数法分成4组。比较各组患者临床特征、冠脉造影结果,入院30天内的死亡、心血管事件和校正的TIMI帧计数(CTFC)和TIMI心肌灌注分级(TMPG)。结果在NLR最高组中,患者年龄较大,入院舒张压偏低,Killip心功能分级Ⅱ至Ⅳ级患者比例较高(P〈0.05),血清肌酐〉133μmol/L患者比例增加;双支病变和三支病变患者比例明显高于其他三组(P〈0.05)。同时,CTFC数值高于其他三组,TMPG0-1级比例亦显著增加。左室射血分数明显降低(P〈0.05);PCI术后30天内的主要心血管事件以及死亡均高于其他3组,具有统计学意义,多元回归分析logNLR与30天内的主要心血管事件相关(r=2.27,P〈0.05)。结论入院时NLR较高的STEMI患者,PCI术后的其心肌灌注较差,且预后不良。 相似文献
16.
Prasad A Stone GW Stuckey TD Costantini CO Mehran R Garcia E Tcheng JE Cox DA Grines CL Lansky AJ Gersh BJ 《The American journal of cardiology》2007,99(8):1067-1071
We examined whether leukocytosis is a negative prognostic factor in patients who underwent primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), and, if so, determined whether it is associated with impaired myocardial perfusion. Previous studies have identified leukocytosis as a predictor of mortality in AMI. Whether this association holds in patients how have undergone primary PCI using contemporary pharmacotherapy and correlates with impaired myocardial perfusion is unknown. Clinical outcomes and reperfusion success, using Thrombolysis In Myocardial Infarction (TIMI) flow and myocardial blush grades, were examined according to tertiles of baseline leukocyte count in 1,268 patients who underwent primary PCI for AMI in the CADILLAC trial. Patients with higher leukocyte count were younger and more likely to be current smokers. Preprocedure TIMI grade 0 flow was more frequent in patients with higher leukocyte counts, but postprocedural TIMI grade 3 flow rates were equally high (>94%) in all 3 groups. Myocardial blush grade 2/3 was achieved at similar rates after PCI in patients with low, intermediate, and high baseline leukocyte counts (52.0% vs 51.5% vs 50.1%, p = 0.8). Higher baseline leukocyte counts were associated with greater myonecrosis (p <0.0001) and increased mortality at 1 year (2.7% vs 4.6% vs 5.4%, respectively, p = 0.047). By multivariate analysis, baseline leukocyte count (in increments of 1,000, hazard ratio 1.07, 95% confidence interval 1.02 to 1.10, p = 0.005) and peak creatine phosphokinase (hazard ratio 1.22, 95% confidence interval 1.14 to 1.29, p <0.001) were independent predictors of 1-year mortality. In conclusion, baseline leukocytosis is an independent correlate of larger infarct and increased mortality after primary PCI in AMI, an effect not explained by decreased myocardial perfusion. 相似文献
17.
Bernard Abi-Saleh Peyman Soltani Nadeem M. Husain Malik Ali Shazib N. Khawaja S. Hinan Ahmed 《Cardiovascular Revascularization Medicine》2009,10(4):224-228
ObjectiveWe sought to evaluate the effects of manual thrombectomy on myocardial reperfusion performed during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).BackgroundComplete reperfusion after primary PCI is compromised by the presence of intraluminal thrombus. Thus effective and safe extraction of thrombus in a timely fashion is important for successful reperfusion.MethodsThirty-two patients (age 51±12 years, males 78%) with STEMI and angiographic evidence of intraluminal thrombus underwent thrombectomy during an 18-month period. Thrombectomy was performed after the presence of thrombus was confirmed angiographically by the operator either before or after primary angioplasty. Thrombectomy was performed using the 6F Export Aspiration Catheter (Medtronic Corporation, Santa Rosa, CA, USA). Myocardial reperfusion using Thrombolysis in Myocardial Infarction (TIMI) flow and myocardial blush grade was assessed by two independent observers.ResultsThe infarct-related artery was left anterior descending (59%), right coronary artery (19%), saphenous venous graft (19%), or left circumflex artery (3%). The coronary lesion was Type B in 62% and Type C in 37% patients, with an average length of 18.2+4.6 mm and reference vessel diameter of 3.2±0.4 mm. The preprocedural TIMI flow was 0 in 62%, 1 in 12%, 2 in 22%, and 3 in 3% of patients. The postprocedural TIMI flow was 0 in 3%, 1 in 6%, 2 in 25%, and 3 in 56% of patients. The postprocedural myocardial blush grade was 0 in 6%, 1 in 9%, 2 in 35%, and 3 in 48% of patients. The in-hospital mortality was 0 and the 30-day mortality was 3%.ConclusionManual thrombectomy using an Export catheter is safe and effective in establishing myocardial reperfusion after STEMI. 相似文献
18.
目的:探讨急性ST段抬高心肌梗死(心梗)(STEMI)急诊经皮冠状动脉介入治疗(PCI)后心肌灌注不良的影响因素。方法:根据PCI后心肌梗死溶栓治疗(TIMI)心肌灌注分级(TMPG),91例患者分为心肌灌注不良组(TMPG0~2级,n=30)和心肌灌注正常组(TMPG3级,n=61),比较2组基本临床资料和造影结果以及介入结果,并对各因素进行Logistio回归分析,总结急性心梗急诊PCI后心肌灌注不良的影响因素。结果:91例患者中男76例,女15例,年龄38~84(62.3±11.8)岁,心肌灌注不良组合并高血压病的比例更高(80.0%比54.1%,P=0.0163),心梗部位以非前壁心梗居多(70.0%比29.5%,P=0.002);造影结果中,心肌灌注不良组梗死相关血管以右冠状动脉(RCA)更多见(63.3%比18.0%,P 相似文献
19.
Karmpaliotis D Turakhia MP Kirtane AJ Murphy SA Kosmidou I Morrow DA Giugliano RP Cannon CP Antman EM Braunwald E Gibson CM;TIMI Study Group 《The American journal of cardiology》2004,94(9):1113-1117
In the setting of ST-segment elevation myocardial infarction (STEMI), the Thrombolysis In Myocardial Infarction (TIMI) risk score (TRS) and indexes of epicardial and myocardial perfusion are associated with mortality. The association between TRS at presentation and angiographic indexes of epicardial and myocardial perfusion after reperfusion therapy has not been investigated. We hypothesized that TRS, TIMI flow grade (TFG), and TIMI myocardial perfusion grade (TMPG) would provide independent prognostic information and that angiographic indexes of poor flow and perfusion would be associated with a higher TRS. TRS and angiographic data were evaluated in 3,801 patients from the TIMI 4, 10A, 10B, 14, 20, 23, and 24 trials. Within each TRS stratum (TRS 0 to 2, 3 to 4, >/=5), 30-day mortality increased stepwise among patients with impaired TFG at 60 minutes after fibrinolytic administration. In a multivariate model adjusting for the TRS strata, impaired TMPG (0/1) was independently associated with higher mortality (odds ratio 2.28, p = 0.018). In a multivariate model adjusting for the TFG and infarct location, the likelihood of impaired TMPG (0/1) was greater among intermediate-risk (TRS 3 to 4) and high-risk (TRS >/=5) patients than among low-risk (TRS 0 to 2) patients (odds ratio 1.43, p = 0.019 and 1.50, p = 0.055, respectively). Thus, impaired epicardial flow and myocardial perfusion are independently associated with increased 30-day mortality among patients identified by TRS as high risk, although there is no synergism between either TFG or TMPG and TRS. High TRS at presentation is associated with abnormal myocardial perfusion, even after adjusting for possible confounders. 相似文献
20.
目的 探讨缺血后处理对老年急性ST段抬高型心肌梗死(STEMI)患者再灌注损伤的保护作用。 方法 连续选择发病12h内行直接经皮冠状动脉介入治疗(PCI)的急性STEMI患者215例,数字抽签法随机分为缺血后处理组和常规治疗组(对照组),两组年龄65岁及以上患者分别为38例和46例。对照组给予单纯再灌注治疗,缺血后处理组采用再灌注30 s,再缺血30 s,交替3次后再持续灌注的方法。分别评估缺血后处理对老年患者再灌注心律失常的发生率、冠状动急性心肌梗死溶栓试验(TIMI)血流分级和心肌组织水平灌注等指标的影响。 结果 缺血后处理组和对照组再灌注心律失常发生率分别为21.1%(8/38)和45.7%(21/46),差异有统计学意义(x2=5.571,P<0.05);其中高危、需要药物或电转复及临时起搏等干预的心律失常发生率分别为7.9%(3/38)和26.1%(12/46),差异有统计学意义(x2=4.695,P<0.05)。校正的TIMI血流帧数(cTFC)分别为(23.6±3.7)帧和(26.1±5.9)帧(t=5.434,P<0.05)。TIMI心肌灌注分级(TMPG)3级分别为89.5%(34例)和69.6%(32例),差异有统计学意义(x2=4.899,P<0.05)。 结论 心肌缺血后处理能减轻老年STEMI患者心肌再灌注损伤,可应用于老年人STEMI再灌注损伤的防治。 相似文献